The Impact of Biologics and Tofacitinib on Cardiovascular Risk Factors and Outcomes in Patients with Rheumatic Disease: A Systematic Literature Review

le Nurmohamed, Michael, Choy, Ernest, Lula, Sadiq, Kola, Blerina, DeMasi, Ryan, Accossato, Paola
Foilsithe in Drug Saf (2018)

Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis

le Cohen, Stanley, Curtis, Jeffrey R., DeMasi, Ryan, Chen, Yan, Fan, Haiyun, Soonasra, Arif, Fleischmann, Roy
Foilsithe in Rheumatol Ther (2018)

Efficacy of Monotherapy with Biologics and JAK Inhibitors for the Treatment of Rheumatoid Arthritis: A Systematic Review

le Emery, Paul, Pope, Janet E., Kruger, Klaus, Lippe, Ralph, DeMasi, Ryan, Lula, Sadiq, Kola, Blerina
Foilsithe in Adv Ther (2018)

Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis

le Fleischmann, Roy M, Huizinga, Tom W J, Kavanaugh, Arthur F, Wilkinson, Bethanie, Kwok, Kenneth, DeMasi, Ryan, van Vollenhoven, Ronald F
Foilsithe in RMD Open (2016)

Tofacitinib in Rheumatoid Arthritis: Lack of Early Change in Disease Activity and the Probability of Achieving Low Disease Activity at Month 6

le van Vollenhoven, Ronald F., Lee, Eun Bong, Fallon, Lara, Zwillich, Samuel H., Wilkinson, Bethanie, Chapman, Douglass, DeMasi, Ryan, Keystone, Edward
Foilsithe in Arthritis Care Res (Hoboken) (2018)

Re-establishment of efficacy of tofacitinib, an oral JAK inhibitor, after temporary discontinuation in patients with rheumatoid arthritis

le Kaine, Jeffrey, Tesser, John, Takiya, Liza, DeMasi, Ryan, Wang, Lisy, Snyder, Mark, Soma, Koshika, Fan, Haiyun, Bandi, Vara, Wollenhaupt, Jürgen
Foilsithe in Clin Rheumatol (2020)

Risk Factors for Major Adverse Cardiovascular Events in Phase III and Long‐Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis

le Charles‐Schoeman, Christina, DeMasi, Ryan, Valdez, Hernan, Soma, Koshika, Hwang, Lie‐Ju, Boy, Mary G., Biswas, Pinaki, McInnes, Iain B.
Foilsithe in Arthritis Rheumatol (2019)

Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial

le Strand, Vibeke, Mysler, Eduardo, Moots, Robert J, Wallenstein, Gene V, DeMasi, Ryan, Gruben, David, Soma, Koshika, Iikuni, Noriko, Smolen, Josef S, Fleischmann, Roy
Foilsithe in RMD Open (2019)

Changes in Lipid Levels and Incidence of Cardiovascular Events Following Tofacitinib Treatment in Patients With Psoriatic Arthritis: A Pooled Analysis Across Phase III and Long‐Ter...

le Gladman, Dafna D., Charles‐Schoeman, Christina, McInnes, Iain B., Veale, Douglas J., Thiers, Bruce, Nurmohamed, Mike, Graham, Dani, Wang, Cunshan, Jones, Thomas, Wolk, Robert, DeMasi, Ryan
Foilsithe in Arthritis Care Res (Hoboken) (2019)

Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study

le Wollenhaupt, Jürgen, Lee, Eun-Bong, Curtis, Jeffrey R., Silverfield, Joel, Terry, Ketti, Soma, Koshika, Mojcik, Chris, DeMasi, Ryan, Strengholt, Sander, Kwok, Kenneth, Lazariciu, Irina, Wang, Lisy, Cohen, Stanley
Foilsithe in Arthritis Res Ther (2019)

Switching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response: efficacy and safety in patients with rheumatoid arthritis

le Fleischmann, Roy M, Blanco, Ricardo, Hall, Stephen, Thomson, Glen T D, Van den Bosch, Filip E, Zerbini, Cristiano, Bessette, Louis, Enejosa, Jeffrey, Li, Yihan, Song, Yanna, DeMasi, Ryan, Song, In-Ho
Foilsithe in Ann Rheum Dis (2021)

Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials

le Cohen, Stanley B, Tanaka, Yoshiya, Mariette, Xavier, Curtis, Jeffrey R, Lee, Eun Bong, Nash, Peter, Winthrop, Kevin L, Charles-Schoeman, Christina, Thirunavukkarasu, Krishan, DeMasi, Ryan, Geier, Jamie, Kwok, Kenneth, Wang, Lisy, Riese, Richard, Wollenhaupt, Jürgen
Foilsithe in Ann Rheum Dis (2017)